Orbital atherectomy versus balloon angioplasty before drug-eluting stent implantation in severely calcified lesions eligible for both treatment strategies (ECLIPSE): a multicentre, open-label, randomised trial.
Kirtane AJ, Généreux P, Lewis B, Shlofmitz RA, Dohad S, Choudary J, Dahle T, Pineda AM, Shunk K, Maehara A, Popma A, Redfors B, Ali ZA, Krucoff M, Armstrong E, Kandzari DE, O'Neill W, Kraemer C, Stiefel KM, Jones DE, Chambers J, Stone GW; ECLIPSE Investigators.
Lancet. 2025 Apr 12;405(10486):1240-1251. doi: 10.1016/S0140-6736(25)00450-7. Epub 2025 Mar 30.
Intravascular ultrasound-guided drug-eluting stent implantation.
Shlofmitz E, Kuku KO, Waksman R, Garcia-Garcia HM.
Minerva Cardioangiol. 2019 Aug;67(4):306-317. doi: 10.23736/S0026-4725.19.04895-3. Epub 2019 Mar 4.
Randomized evaluation of vessel preparation with orbital atherectomy prior to drug-eluting stent implantation in severely calcified coronary artery lesions: Design and rationale of the ECLIPSE trial.
Généreux P, Kirtane AJ, Kandzari DE, Armstrong EJ, Krucoff MW, Redfors B, Ben-Yehuda O, Lerew DR, Ali ZA, Maehara A, O'Neill WW, Stone GW.
Am Heart J. 2022 Jul;249:1-11. doi: 10.1016/j.ahj.2022.03.003. Epub 2022 Mar 12.
Vascular Response Following Drug-Eluting Stent Implantation in Calcified Coronary Lesions: 2 Major Clinical Questions Emerged.
Kitabata H.
Cardiovasc Revasc Med. 2022 Aug;41:61-62. doi: 10.1016/j.carrev.2022.05.024. Epub 2022 May 20.
Coronary Artery Bypass at a Drug-Eluting Resorbable Magnesium Scaffold Site in a Porcine Model.
Cohen JE, Garcia-Garcia HM, Hellinga D, Kolodgie F, Virmani R, Finn A, Waksman R.
Cardiovasc Revasc Med. 2022 Sep;42:109-113. doi: 10.1016/j.carrev.2022.02.026. Epub 2022 Feb 28.
Comparison of the efficacy of intravascular lithotripsy and rotational atherectomy as adjunctive therapy before drug-eluting stent implantation in calcified coronary lesions (CCS- Coronary Calcification Study).
Pleva L, Kukla P, Konde A.
BMC Cardiovasc Disord. 2025 Sep 2;25(1):648. doi: 10.1186/s12872-025-05082-z.
Resistant in-stent restenosis in the drug eluting stent era.
Theodoropoulos K, Mennuni MG, Dangas GD, Meelu OA, Bansilal S, Baber U, Sartori S, Kovacic JC, Moreno PR, Sharma SK, Mehran R, Kini AS.
Catheter Cardiovasc Interv. 2016 Nov;88(5):777-785. doi: 10.1002/ccd.26559. Epub 2016 May 17.
High-speed rotational atherectomy in coronary artery calcification: The randomized ROTAXUS and PREPARE-CALC trials.
Liang B, Gu N.
Catheter Cardiovasc Interv. 2022 Jul;100(1):61-71. doi: 10.1002/ccd.30119. Epub 2022 Feb 7.
Ultrathin Biodegradable-Polymer Orsiro Drug-Eluting Stent Performance in Real Practice Challenging Settings.
Rigatelli G, Zuin M, Gianese F, Adami D, dell'Avvocata F, Barison S, Mazza A, Picariello C, Roncon L.
Cardiovasc Revasc Med. 2021 Sep;30:12-17. doi: 10.1016/j.carrev.2020.09.027. Epub 2020 Sep 23.
Impact of Coronary Calcification on Clinical Outcomes After Implantation of Newer-Generation Drug-Eluting Stents.
Hemetsberger R, Abdelghani M, Toelg R, Mankerious N, Allali A, Garcia-Garcia HM, Windecker S, Lefèvre T, Saito S, Slagboom T, Kandzari D, Koolen J, Waksman R, Richardt G.
J Am Heart Assoc. 2021 Jun 15;10(12):e019815. doi: 10.1161/JAHA.120.019815. Epub 2021 May 29.
